1-3 of 3
Sven Björkman
Close
Sort by
Journal Articles

Use of a Population Pharmacokinetic Model of ADVATE In Pediatric and Adult Patients with Hemophilia A Permits Limited Blood Sampling for Individual Dose Tailoring.

MyungShin Oh, Sven Björkman, Phillip Schroth, Sandor Fritsch, Peter W Collins, Kathelijn Fischer, Victor S. Blanchette, Kathleen M. Casey, Gerald Spotts, Bruce M. Ewenstein
Journal: Blood
Blood (2010) 116 (21): 1416.
https://doi.org/10.1182/blood.V116.21.1416.1416
Published: 2010
Journal Articles

Population Pharmacokinetic Model of ADVATE in Pediatric and Adult Patients with Hemophilia A.

Myungshin Oh, PhD, Sven Björkman, PhD, Phillip Schroth, Sandor Fritsch, PhD, Peter Collins, MD, Kathelijn Fischer, MD, PhD, MSc, Victor S. Blanchette, MD, Kathleen M. Casey, PhD, Gerald Spotts, PhD, Bruce M. Ewenstein, MD, PhD
Journal: Blood
Blood (2009) 114 (22): 3492.
https://doi.org/10.1182/blood.V114.22.3492.3492
Published: 2009
Journal Articles

Effect of Normal Variation in Factor VIII Pharmacokinetics on Prophylactic Dosing Requirements in Severe Classical Hemophilia.

Peter Collins, Kathelijn Fischer, MD, PhD, MSC, Victor S. Blanchette, FRCP, Sven Björkman, Myungshin Oh, Phillip Schroth, Kathleen M. Casey, PhD, Gerald Spotts, PhD, Sandor Fritsch, Bruce M. Ewenstein, MD, PhD
Journal: Blood
Blood (2008) 112 (11): 1222.
https://doi.org/10.1182/blood.V112.11.1222.1222
Published: 2008